Francisco A Moreno, MD
Professor of Psychiatry
Executive Vice Chair
University of Arizona College of Medicine
Tucson, AZ
Our stellar host faculty at the University of Arizona and distinguished guest speakers for our 2013 course included:
Geoffrey Ahern, MD, PhD
Sally Boeve, MD
Pedro L. Delgado, MD
Philip Eichling, MD, MPH
Marlene P. Freeman, MD
Steven Galper, MD, JD
Alan J. Gelenberg, MD
Jaswinder Ghuman, MD
G. Alex Hishaw, MD
Terence A. Ketter, MD
Marianne Klugheit, MD
John Leipsic, MD
Francisco Moreno, MD
Henry A. Nasrallah, MD
Charles Raison, MD
Robert Rhode, PhD
Kathy W. Smith, MD
Ole J. Thienhaus, MD, MBA
Brief Bios:
Geoffrey Ahern, MD, PhD, Professor of Neurology, Psychology, Psychiatry, and the Evelyn F. McKnight Brain Institute; Bruce and Lorraine Cumming Endowed Chair in Alzheimer's Research; Medical Director, Behavioral Neuroscience and Alzheimer's Clinic, University of Arizona. Dr. Ahern received his PhD in Psychology and MD from Yale University. He completed his residency in Neurology at Boston University and then went on to a fellowship in Behavioral Neurology at Beth Israel Hospital in Boston. He is certified in Neurology by the American Board of Psychiatry and Neurology and in Behavioral Neurology & Neuropsychiatry by the United Council for Neurological Subspecialties. Dr. Ahern has directed the Behavioral Neuroscience and Alzheimer’s Clinic at University of Arizona since his arrival in 1990. Since 1990, Dr. Ahern has participated in some 40 clinical trials of agents to treat and/or diagnose Alzheimer’s disease. For the past 9 years, Dr. Ahern has been the director of the University of Arizona Clinical Core, which is part of the multi-site Arizona Alzheimer’s Disease Core Center (ADCC), funded by the NIA.
Sally Boeve, MD, Assistant Professor of Psychiatry at the University of Arizona College of Medicine. After attending medical school at Loyola University in Illinois, she completed her Psychiatry Residency and Child and Adolescent Psychiatry Fellowship at the University of Arizona. She is a member of the American Academy of Child and Adolescent Psychiatry, American Psychiatric Association, and has worked at Sonora Behavioral Health, Palo Verde Behavioral Health Hospital, and University of Arizona Medical Center.
Pedro L. Delgado, MD, Professor and Dielmanm Distinguished Chair of Psychiatry, Professor of Pharmacology, The University of Texas Health Science Center at San Antonio, TX. Dr. Delgado received his BS in Biology summa cum laude from the University of Houston and his MD and MA in Pharmacology from University of Texas Medical Branch in Galveston, TX. He completed his internship and psychiatry residency at Yale University School of Medicine and served on the Yale Faculty until 1992, leading research programs investigating the neurobiological basis of depression and the mechanisms of antidepressant drug action. Over the past 20 years, he has served on the faculty at Yale University School of Medicine, the University of Arizona College of Medicine, and Case Western Reserve School of Medicine. He was Douglas Danford Bond Professor and Chairman of Psychiatry at Case Western Reserve University School of Medicine (2000-2005) prior assuming his current position as Psychiatry Department Chairman in San Antonio, Texas. Dr. Delgado’s primary research interests have focused on investigation of the neurobiology and treatment of mood and stress disorders, human emotion, and the neurobiological mechanisms of antidepressant action. Dr. Delgado is most known for his groundbreaking work using neurotransmitter depletion to study antidepressant mechanisms. For his work investigating the biology of depression, he shared the international Anna Monika Prize in 1995. He has published over 100 scientific articles and book chapters concerning these and related topics. He serves on the editorial boards of many prominent psychiatric journals, is a grant reviewer for NIH, and is a frequent lecturer on biological aspects of depression and clinical use of antidepressant drugs. He has a longstanding commitment to research mentoring and clinician scientist training and along with his role as psychiatry department chairman, he is the director of the UTHSCSA Clinical and Translational Science Award (CTSA) KL2 early career scientist training program.
Philip Eichling, MD, MPH, UA Associate, Medical Director of Comprehensive Sleep Solutions. Dr. Eichling is originally from Chicago where he did graduate work in social ethics at the University of Chicago before going off to New York University for his medical school training. He received a joint MD/MPH between NYU and Harvard School of Public Health. After medicine residency at Boston City Hospital, he came to Arizona with the Public Health Service. He served in the National Health Corps for 3 years and qualified for family practice board certification, in addition to his internal medicine training. In 1988 he took the job of Medical Director for the Canyon Ranch medical department. He headed the preventive medicine residency committee at the University of Arizona for several years and has taught preventive medicine continuously for 20 years to medical students and residents. Preventive cardiology brought Dr Eichling to sleep medicine 15 years ago when he saw patients with untreated apnea who were unable to make health changes until they became less sleepy. He set up a sleep lab in 1993 at Canyon Ranch. He has continuously been practicing sleep medicine ever since. From 2000 on he has been practicing at the Sleep Disorders Center at the University of Arizona, in addition to his preventive medicine practice. He became sleep board certified in 2002 and opened a private practice of sleep medicine in 2005. He is one of the first to have passed the newly developed sleep board under the American Board of Internal Medicine. He is a fellow of the American Academy of Sleep Medicine. He has published several articles on sleep medicine and given numerous medical education presentations to professional and lay audiences.
Marlene P. Freeman, MD, Associate Professor of Psychiatry at Harvard Medical School, Director of Clinical Services in Perinatal and Reproductive Psychiatry Clinical Research Program at Massachusetts General Hospital. Dr. Freeman’s clinical and research experience has been focused on antenatal and postpartum depression, as well as integrative treatment strategies for mood disorders. She completed undergraduate work at University of Wisconsin, medical school at Northwestern University Medical School, and residency at the Harvard Longwood Psychiatry Residency Program. Dr. Freeman served as a co-investigator in the first clinical trial of adjunctive omega-3 fatty acids for the treatment of bipolar disorder. After residency, she completed a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine, focused on bipolar disorder treatment research. Dr. Freeman established the University of Arizona’s Women’s Mental Health Program in 2000 and directed the program for seven years. She developed a research program in perinatal depression with grant support from NARSAD, the National Institute of Mental Health, the U.S. FDA, the Arizona Disease Control Research Commission, and the Institute for Mental Health Research. These grants supported research in perinatal depression. From 2007-8, she served as the Director of the Women’s Mental Health Center at UT Southwestern Medical Center. She serves as Vice Editor-in-Chief for The Journal of Clinical Psychiatry since 2007, after serving as Deputy Editor since 2003. She chaired a subcommittee on Omega-3 Fatty Acids in Psychiatry, on behalf of the American Psychiatric Association (APA). She currently chairs the APA’s Task Force on Complementary and Alternative Medicine. She served on the APA’s Major Depressive Disorder Treatment Guideline Revision.
Steven R. Galper, MD, JD, Clinical Assistant Professor of Psychiatry and Anesthesiology, University of Arizona College of Medicine, Director of Mental Health for Pima County Adult Detention Complex, Medical Director of Behavioral Health for Marana Health Center. Dr. Galper is a pain management specialist, a neurologist and a psychiatrist. He attended the University of Arizona College of Medicine and was the first resident in the combined neurology-psychiatry residency program. Dr. Galper was Fellowship trained at the UA in the Dept. of Anesthesiology in Pain Management. Dr. Galper is also an attorney, although his license is currently inactive. His experience includes prior practice at Old Pueblo Pain Associates, was the Director of the Pain Program at Sierra Tucson, and practiced neurology for the Northwest Hospital system. He has served as Medical Director of Marana Health Center Behavioral Health Services in Marana, Arizona, since 2010, and as Director of Mental Health with Pima County Adult Detention Complex in Tucson since 2009. Dr. Galper has also maintained a private medical practice in Psychiatry and Pain Management at Independent Behavioral Health Associates for the past three years. In addition, he recently accepted a position at the University of Arizona Pain Clinic, where he specializes in pain management as a Clinical Assistant Professor of Anesthesiology. Dr. Steven Galper enjoys hospital affiliations with Cornerstone Hospital of Southeast Arizona and University Physicians Healthcare Hospital in Tucson.
Alan J. Gelenberg, MD, Shively-Tan Professor and Chair of Psychiatry at Penn State University. Dr. Gelenberg is Editor-in-Chief of the Journal of Clinical Psychiatry, the field’s most widely read peer-reviewed journal, and founding author of Biological Therapies in Psychiatry Newsletter. For 18 years, he was Professor and Head of the University of Arizona’s Department of Psychiatry, after which he was President and CEO of Healthcare Technology Systems of Madison, WI, and Clinical Professor at the University of Wisconsin. Dr. Gelenberg has been on the faculties of Harvard, Massachusetts General Hospital, and MIT. Dr. Gelenberg has been the lead author of manuscripts in the Lancet, New England Journal of Medicine, JAMA, and has published over 280 scientific articles, editorials, and book chapters. He chaired the American Psychiatric Association’s (APA) workgroup on Treatment Guidelines for Major Depressive Disorder, 3rd edition, was on a joint APA/AMA taskforce on similar guidelines for primary care and a committee to advise the CDC about depression. He helped create the ASEX scale to monitor sexual side effects of antidepressants and electronic versions of suicide-assessment instruments. Often a guest lecturer and visiting professor throughout the world, Dr. Gelenberg has been on NIMH committees, is a Distinguished Life Fellow of the APA, former chair of its Committee on Research on Psychiatric Treatments, past President of the West Coast College of Biological Psychiatry, fellow of the American College of Neuropsychopharmacology, and member of the American College of Psychiatrists. Consistently listed in The Best Doctors in America, he received an Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill and two teaching awards at the University of Arizona. Dr. Gelenberg received his AB degree from Columbia University and MD from the University of Pennsylvania.
Jaswinder K. Ghuman, MD, Associate Professor of Psychiatry and Pediatrics, Director of the Infant and Preschool Program, Child and Adolescent Psychiatry, University of Arizona. Dr. Ghuman is board certified both in general psychiatry and child and adolescent psychiatry. In addition to conducting research on the efficacy and safety of methylphenidate in young children with Autistic Disorder/ Autism Spectrum Disorders, she provides clinical services to preschool children with developmental and psychiatric disorders. Dr. Ghuman received her MBBS (MD) degree in 1973 from the Christian Medical College, Punjab University, India. She completed general psychiatry training at Rochester Psychiatric Center and Washington University, St. Louis, Mo., and Child and Adolescent Psychiatry Fellowship training at The Johns Hopkins University from 1986-1988. Dr. Ghuman developed and directed the Infant and Preschool Clinic at the Kennedy Krieger Institute, Johns Hopkins University. She was appointed by the Governor to the Maryland Advisory Council on Attention Deficit Hyperactivity Disorder. Dr. Ghuman received an NIMH sponsored Minority Supplement grant and developed a parent and teacher questionnaire, the Ghuman-Folstein Screen for Social Interaction, to screen for social interaction in 6 months to 5 year old children with autism, PDD and other developmental disorders. Dr. Ghuman was co-investigator in the multisite risperidal, methylphenidate and guanfacine studies in children and adolescents with PDD for the NIMH sponsored Autism RUPP Network. She was also co-PI in the NIMH sponsored multisite Preschool ADHD Treatment Study. Dr. Ghuman is conducting treatment studies in young children with PDD and ADHD. She has been the Principal Investigator for NIMH sponsored Methylphenidate Study in Young Children with PDD.
G. Alex Hishaw, MD, Assistant Professor of Neurology and Psychiatry, University of Arizona College of Medicine, Staff Neurologist at Southern Arizona VA Health Care System (SAVAHCS). Dr. Hishaw splits his time between neuropsychiatric management of Head Injury at SAVAHCS and directing Dementia/Neurobehavioral management on the University of Arizona Medical Center South Campus. Dr. Hishaw obtained a BS in Biology from University of Missouri-Columbia in 1996 and MD from University of Missouri-Columbia School of Medicine in 2001. He completed his internship at University of Arizona in 2002. In 2007, he finished combined Neurology and Psychiatry Residencies at University of Arizona and was the first resident to become Chief in both the Neurology and Psychiatry departments. Dr. Hishaw finished the McKnight Behavioral Neurology/ Neuropsychology Fellowship at University of Arizona in 2008. His clinical and research activities include: Head Injury; Dementia; Behavioral Neurology; Neuropsychiatry; and Intracarotid Amobarbital (Wada) Test.
Terence A. Ketter, MD, Professor of Psychiatry & Behavioral Sciences and Chief of the Bipolar Disorders Clinic at the Stanford University School of Medicine in Stanford, California. Dr. Ketter obtained his medical degree from the University of Toronto and completed his internship and residency training in psychiatry at the University of California at San Francisco. He had subsequent fellowship training in brain imaging and psychopharmacology research methods at the Biological Psychiatry Branch of the National Institute of Mental Health in Bethesda, MD. Dr. Ketter's research interests include the use of brain imaging methods such as positron emission tomography (PET), magnetic resonance imaging (MRI), and magnetic resonance spectroscopy (MRS) to better understand the neurobiology of mood disorders and to explore the possibility of using these techniques to more effectively target treatments for patients with bipolar disorders. Dr. Ketter also conducts research in the use of novel medications and combinations of medications in the treatment of bipolar disorders, with an emphasis on the use of anticonvulsants. In constant demand as a speaker, he presents at numerous national and international conferences and advisory boards, and sits on the review panel of several major scientific journals. At Stanford, he serves on the Institutional Review Board, the body responsible for reviewing all new research proposals for scientific soundness, ethical conduct, and protection of human subjects. Inspired by his clinical work with exceptionally creative individuals, Dr. Ketter has developed a strong interest in the relationship of creativity and mood disorders. In addition to his regular medical school and residency teaching duties, he is currently teaching a sophomore seminar course on Mood, Temperament, and Creativity. He is a featured panelist on the Stanford Alumni Association's Think Again tour.
Marianne Klugheit, MD, staff psychiatrist at the Southern Arizona VA Health Care System and Assistant Professor of Clinical Psychiatry at the University of Arizona. Dr. Klugheit was born and raised in Philadelphia. She completed two years of a surgery residency and was then commissioned as an officer in the Public Health Service. Afterwards, she completed her psychiatry residency at the University of Pennsylvania in Philadelphia. Working in community psychiatry, she was outpatient director of Hall-Mercer Community Mental Health Center at Pennsylvania Hospital. She has also worked in Geropsychiatry at Albert Einstein Medical Center and was Medical Director of Northwestern Human Services. Finally, she was associate chair of the department of Psychiatry at Albert Einstein Medical Center in Philadelphia. In Tucson since 2002, AZ, Dr. Klugheit worked at La Frontera Center prior to joining the Southern Arizona VA Health Care System.
John Leipsic, MD, Assistant Professor of Child and Adolescent Psychiatry and Director of Pediatric Psychiatry Consultation and Liaison Service, University of Arizona. Dr. Leipsic is a highly experienced and renowned child and adolescent psychiatrist who specializes in pediatric psychopharmacology and uses medication in conjunction with psychotherapy and behavioral therapy. He recently joined the University of Arizona after 15 years of private practice at North Bay Behavioral Health in Sonoma County. Dr. Leipsic attended the University of California, Berkeley where he studied Neurobiology, and received his medical degree from the Medical College of Virginia in Richmond, Virginia in 1989. After completion of internship at Tufts University in Boston, Dr. Leipsic trained at St. Elizabeth's Hospital in Boston for his adult residency. He completed his child and adolescent psychiatry fellowship in 1994 at the University of California, Davis. Dr. Leipsic was most recently in private practice in Sonoma County, California for 15 years. He is director of the pediatric psychiatry consultation and liaison service at the University of Arizona Medical Center - University Campus and also on staff at the Crisis Response Center's child and adolescent crisis evaluation and stabilization unit. Dr. Leipsic takes a direct and practical approach to psychiatry consultation and liaison. When there is a mental health issue or question on patients in the emergency room, PICU or pediatric floors, the pediatric psychiatry consult service can be there from the point of admission to help clarify diagnosis, developmental and family impacts of illness, treatment recommendations and follow-up. Dr. Leipsic has a specialty interest in the overlap of Tourette’s and anxiety disorders such as obsessive compulsive disorder.
Francisco Moreno, MD, Professor of Psychiatry and Executive Vice Chair, University of Arizona College of Medicine. Dr. Moreno conducts research in biology and treatment of mood and anxiety disorders, geared to improve our understanding of the brain basis for mental illness and the underlying mechanism of action of antidepressants/ antianxiety drugs, and treatment resistance. He is originally from Mexico where he obtained his MD at the University of Baja California, then completed his psychiatry residency and research training in Neuropsychopharmacology at The University of Arizona Health Sciences. Dr. Moreno through his research collaborations utilizes various research methodologies such as molecular, biochemical, electrophysiological and behavioral correlates of depression. His work is funded by grants from the National Institutes of Health, private foundations, and collaborations with industry. He has supervised and mentored a number of interdisciplinary students, psychiatry residents, research fellows and junior faculty. His clinical interest and expertise include treatment resistant mood and anxiety disorders, and he serves often as a psychopharmacology consultant to government institutions, health insurances, and pharmaceutical/device industry. Dr. Moreno is the Course Director for the Annual Psychopharmacology Review Course.
Henry A. Nasrallah, MD, Professor of Psychiatry and Neuroscience, Associate Dean, University of Cincinnati College of Medicine. Dr. Nasrallah is a widely recognized psychiatrist, educator and researcher. Following psychiatric residency at the University of Rochester and neuroscience fellowship at the NIH, he served as chair of Ohio State University Department of Psychiatry for 12 years. In 2003, he joined University of Cincinnati. Dr. Nasrallah’s research focuses on the neurobiology and psychopharmacology of schizophrenia and related psychoses. He has published over 380 scientific articles as well as 11 books. He is Editor-In-Chief of two journals (SCHIZOPHRENIA RESEARCH and CURRENT PSYCHIATRY) and co-founded the Schizophrenia International Research Society (SIRS). He is board certified in both adult and geriatric psychiatry. He is a distinguished fellow of the American Psychiatric Association, and has served as president of the Cincinnati Psychiatric Society and as president of the American Academy of Clinical Psychiatrists. He has twice received the NAMI Exemplary Psychiatrist Award and was chosen as the USA Teacher of the Year by the Psychiatric Times. He has received over 85 research grants and is listed in several editions of the book “Best Doctors in America.”
Charles Raison, MD, Associate Professor of Psychiatry and Integrative Mental Health, College of Medicine and Norton School of Family and Consumer Sciences, University of Arizona. Dr. Raison is an accomplished researcher whose work focuses on inflammation and the development of depression in response to illness and stress. He aims to translate neurobiological findings into novel pharmacological and behavioral interventions. Dr. Raison serves as a mental health expert for CNNhealthcare.com and frequently appears in other media outlets. He was the 2011 Chair of the U.S. Psychiatric and Mental Health Congress. After attending medical school at Washington University in Saint Louis, he completed his residency in Psychiatry at UCLA where he served as Chief Resident of Adult Inpatient Services. Dr. Raison was the Director of Emergency Psychiatry Services and Attending Physician of the Adult Inpatient Service at the UCLA Neuropsychiatric Institute and Hospital before moving to Emory University where he secured a Scientist Development Award for Clinicians from the National Institutes of Mental Health to launch his scientific career. He previously was with Emory University in Atlanta, GA, where he was an Associate Professor in the Department of Psychiatry and Behavioral Sciences, Clinical Director of the Emory Mind Body Program, and Director of the Behavioral Immunology Clinic.
Robert Rhode, PhD, Clinical Lecturer at University of Arizona Psychiatry. Dr. Rhode is a clinical psychologist who has been publishing and presenting on motivational interviewing for over 10 years. He presents at conferences all over the country, in addition to regularly lecturing to medical students at the University of Arizona College of Medicine. He has published in peer reviewed journals on the training of motivational interviewing. In his own clinical work, he uses this style to help clients with a variety of health behaviors including losing weight, increasing exercise, and decreasing substance use. He has conducted motivational interviewing trainings for groups as small as three and as large as 300, for physicians, counselors, nurses, social workers, parole officers, and students. Participants in his workshops have had clients who are overcoming mental disorders, substance use disorders, dual disorders, homelessness, or improving health related behaviors.
Kathy W. Smith, MD, Assistant Professor at the University of Arizona College of Medicine Department of Psychiatry. Dr. Smith works at the Crisis Response Center in Tucson, AZ. She completed her Bachelor of Science degree at Arizona State University in Microbiology and received her MD from University of Arizona College of Medicine in 2001. After graduating from medical school, she stayed at University of Arizona to complete her residency training in General Psychiatry and fellowship training in Child and Adolescent Psychiatry. She has had additional specialized training in women's mental health and was the Director of the Women's Mental Health Program at the University of Arizona for two years before starting a private practice in the Tucson community. Dr. Smith specializes in treating ADHD in women, preconception and pregnancy planning for women using psychiatric medications, and the treatment of mood and anxiety disorders during pregnancy and the postpartum. Dr. Smith is board-certified in both adult and child and adolescent psychiatry.
Ole J. Thienhaus, MD, MBA, Professor and Chair of Psychiatry, University of Arizona College of Medicine. Dr. Thienhaus was appointed Department Chair in March 2012, transferring from Las Vegas, Nevada, where he had been Chair of Psychiatry at the University of Nevada School of Medicine since 1996. Previously he had been Associate Professor of Psychiatry and Vice Chair for Administration at the Department of Psychiatry of the University of Cincinnati College of Medicine. Dr. Thienhaus earned his medical degree from the Free University of Berlin, West Germany, in 1978, and his MBA in marketing and management from the University of Cincinnati in 1985. He completed a fellowship in geriatric psychiatry in 1984 and a residency in psychiatry in 1983 at the University of Cincinnati and an internship in general surgery in Germany in 1979. He serves as a senior examiner for specialty board examinations and as a member of the Maintenance of Certification Committee of the American Board of Psychiatry and Neurology. He also is a consultant to the Center for Medicare and Medicaid Services of the Hospital Accreditation Program in the U.S. Department of Health and Human Services. He is an ad hoc study section reviewer for the National Institutes of Health (epidemiology) and the National Institute of Mental Health (geriatrics). Dr. Thienhaus is a distinguished fellow of the American Psychiatric Association and a fellow of the American College of Psychiatrists and the Arnold P. Gold Humanism Honor Society. He has received numerous awards and honors, including the Cancro Academic Leadership Award of the American Academy of Child and Adolescent Psychiatry, presented in 2011; and the Nevada Business Journal's Healthcare Hero Award, the Senatorial Recognition for Service on the Sanford Center for Aging Scholarship Committee and the U.S. Senate Certificate of Commendation: Celebration of Scholars in Aging, all presented in 2010. He also has been a visiting professor at Phramongkutklao College of Medicine, Bangkok, and the University of Chang Mai School of Medicine, Chang Mai, Thailand; and the University of Kyrgyzstan College of Medicine in Bishkek. Dr. Thienhaus is the author or editor of several books, including "Correctional Psychiatry, Volumes I and II," "Manual of Hospital Psychiatry," and, in a different vein altogether, "Jewish-Christian Dialogue - The Example of Gilbert Crispin." His scientific articles have appeared in many publications, including the Journal of Clinical Psychiatry, American Family Physician, American Journal of Psychiatry, Psychiatric Services, Journal of Psychoactive Drugs, Harvard Mental Health Letter and Psychiatric Times. He serves on the editorial boards of the International Journal of Offender Therapy and Comparative Criminology and the Annals of Pharmacotherapy. He is certified by the American Board of Psychiatry and Neurology, with an additional qualification in geriatric psychiatry, and is licensed by the Arizona Board of Medical Examiners.
Photos by John Miranda
